Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies

Journal of Neuropathology and Experimental Neurology
M MirabellaValerie Askanas

Abstract

Sporadic inclusion-body myositis (s-IBM) and the hereditary inclusion-body myopathies (h-IBMs) are severe and progressive muscle diseases, characterized pathologically by vacuolated muscle fibers containing paired-helical filaments (PHFs). An interesting feature of the s- and h-IBM muscle phenotype is its striking similarity to Alzheimer-disease (AD) brain. We immunostained muscle biopsies of 9 s-IBM patients, 9 autosomal-recessive h-IBM patients, 1 autosomal-dominant h-IBM patients, and 18 normal and disease-controls with several antibodies known to react with the hyperphosphorylated tau of AD-PHFs. Those included SMI-31, SMI-310, PHF-1, and AT8. In both s- and h-IBM, virtually all vacuolated muscle fibers had strongly immunoreactive inclusions with SMI-31, and by immuno-electronmicroscopy SMI-31 was exclusively localized to PHFs. Approximately 40 to 50% of both s- and h-IBM vacuolated muscle fibers were also immunoreactive with AT8 antibody. To the contrary, in h-IBM, there was no immunoreactivity with SMI-310 and PHF-1 antibodies, whereas in s-IBM the vacuolated muscle fibers had strong immunoreactivity with those two antibodies. By immunoelectronmicorscopy, SMI-310 and PHF-1 also were localized to PHFs. Within s-IBM muscle ...Continue Reading

Citations

Aug 17, 2010·Acta Neuropathologica·Anna NogalskaValerie Askanas
Sep 6, 2008·Molecular Neurobiology·Daniela L RebolledoNibaldo C Inestrosa
Mar 6, 2003·Experimental Neurology·Gaetano VattemiValerie Askanas
Jun 8, 2000·Neuroscience Letters·A BroccoliniV Askanas
Jul 23, 1998·Neuromuscular Disorders : NMD·B UddH Somer
Jun 23, 2009·The Journal of Biological Chemistry·Rajat PuriSubramaniam Ganesh
Sep 27, 2013·Current Opinion in Rheumatology·Steven A Greenberg
Oct 6, 2007·Current Opinion in Rheumatology·Valerie Askanas, W King Engel
Jul 29, 2010·Current Opinion in Neurology·Conrad C Weihl, Alan Pestronk
Jul 23, 2009·BMJ : British Medical Journal·Steven A Greenberg
Dec 20, 2007·Journal of Neuropathology and Experimental Neurology·Eiji MatsuuraMitsuhiro Osame
Mar 30, 2011·Rheumatic Diseases Clinics of North America·Brent T Harris, Carrie A Mohila
Apr 24, 2010·Neuromuscular Disorders : NMD·Olivier Benveniste, David Hilton-Jones
May 16, 2015·Journal of Neuropathology and Experimental Neurology·Anna NogalskaValerie Askanas
Jan 15, 2008·Neuroscience Letters·Theresa J KannanayakalJeff Kuret
Aug 10, 2006·Journal of Neuropathology and Experimental Neurology·Jie LiElisabeth J Rushing
Jun 18, 2009·Muscle & Nerve·Mohammad SalajeghehSteven A Greenberg
Jul 25, 2009·Muscle & Nerve·Mohammad SalajeghehSteven A Greenberg
Jul 21, 2009·Muscle & Nerve·Aldobrando BroccoliniMassimiliano Mirabella
Feb 8, 2005·Neuromuscular Disorders : NMD·Aldobrando BroccoliniMassimiliano Mirabella
Jan 28, 2014·Neurobiology of Aging·Andrea CortesePietro Fratta
Aug 26, 2014·Biochimica Et Biophysica Acta·Aldobrando Broccolini, Massimiliano Mirabella
Jan 24, 2017·Neuropathology and Applied Neurobiology·C C Weihl, A L Mammen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.